Correlation Between Takeda Pharmaceutical and TERADATA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and TERADATA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and TERADATA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and TERADATA, you can compare the effects of market volatilities on Takeda Pharmaceutical and TERADATA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of TERADATA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and TERADATA.

Diversification Opportunities for Takeda Pharmaceutical and TERADATA

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Takeda and TERADATA is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and TERADATA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TERADATA and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with TERADATA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TERADATA has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and TERADATA go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and TERADATA

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the TERADATA. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 1.14 times less risky than TERADATA. The stock trades about -0.05 of its potential returns per unit of risk. The TERADATA is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  2,540  in TERADATA on September 3, 2024 and sell it today you would earn a total of  400.00  from holding TERADATA or generate 15.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.38%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  TERADATA

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
TERADATA 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TERADATA are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, TERADATA unveiled solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and TERADATA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and TERADATA

The main advantage of trading using opposite Takeda Pharmaceutical and TERADATA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, TERADATA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TERADATA will offset losses from the drop in TERADATA's long position.
The idea behind Takeda Pharmaceutical and TERADATA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum